Benjamin Halladay

Insider Reports History

Entity
Individual
Location
Esperion Therapeutics, Inc., 3891 Ranchero Drive, Suite 150, Ann Arbor, MI
Signature
/s/ Sheldon L. Koenig, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Benjamin Halladay:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Esperion Therapeutics, Inc. Chief Financial Officer Common Stock 244K $92.1K $1.25 Mar 14, 2024 Direct
Esperion Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 200K Mar 14, 2024 Direct

Insider Reports Filed by Benjamin Halladay

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ESPR Esperion Therapeutics, Inc. Mar 14, 2024 2 $0 4 Mar 15, 2024 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Mar 14, 2023 2 $0 4 Mar 15, 2023 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Dec 9, 2022 2 $0 4 Dec 12, 2022 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Nov 16, 2022 0 $0 3 Nov 16, 2022 Chief Financial Officer